Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Alzheimer’s disease (AD) is the most common neurodegenerative disease. Growing evidence suggests an important role for gut dysbiosis and gut microbiota-host interactions in aging and neurodegeneration. Our previous works have demonstrated that supplementation with the nicotinamide adenine dinucleoti...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Xixia Chu, Yujun Hou, Qiong Meng, Deborah L. Croteau, Yong Wei, Supriyo De, Kevin G. Becker, Vilhelm A. Bohr
Materialtyp: Artikel
Språk:English
Publicerad: Frontiers Media S.A. 2022-09-01
Serie:Frontiers in Aging Neuroscience
Ämnen:
Alzheimer’s disease
nicotinamide riboside
gut microbiome
APP/PS1 transgenic mice
neuroinflammation
aging
Länkar:https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

Liknande verk